Current Strategies to Enhance Anti-Tumour Immunity
AbstractThe interaction of the immune system with cancer is complex, but new approaches are resulting in exciting therapeutic benefits. In order to enhance the immune response to cancer, immune therapies seek to either induce high avidity immune responses to tumour specific antigens or to convert the tumour to a more pro-inflammatory microenvironment. Strategies, including vaccination, oncolytic viruses, and adoptive cell transfer all seek to induce anti-tumour immunity. To overcome the suppressive tumour microenvironment checkpoint inhibitors and modulators of regulatory cell populations have been investigated. This review summarizes the recent advances in immune therapies and discusses the importance of combination therapies in the treatment of cancers. View Full-Text
Share & Cite This Article
Cook, K.W.; Durrant, L.G.; Brentville, V.A. Current Strategies to Enhance Anti-Tumour Immunity. Biomedicines 2018, 6, 37.
Cook KW, Durrant LG, Brentville VA. Current Strategies to Enhance Anti-Tumour Immunity. Biomedicines. 2018; 6(2):37.Chicago/Turabian Style
Cook, Katherine W.; Durrant, Lindy G.; Brentville, Victoria A. 2018. "Current Strategies to Enhance Anti-Tumour Immunity." Biomedicines 6, no. 2: 37.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.